Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Nitric Oxide (NO) Supplementation on Neurocognitive Measures in Argininosuccinate Lyase Deficiency (ASLD)

NCT03064048 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT03064048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03064048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Nitric Oxide (NO) Supplementation on Neurocognitive Measures in Argininosuccinate Lyase Deficiency (ASLD)
Lead sponsor
Baylor College of Medicine
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2017
Completion date
January 31, 2023
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

argininosuccinate lyase deficiency, argininosuccinic aciduria, urea cycle disorder, urea cycle disorders, inborn